По вашему запросу найдено документов: 318

Страница 6 из 32

Роль ингибиторов EGFR 2-го поколения в терапии рака легкого в реалиях современной клинической практики
The role of second-generation EGFR inhibitors in lung cancer therapy in the realities of modern clinical practice
ИЗМАЙЛОВ, А.А., НАСРЕТДИНОВ, А.Ф., СУЛТАНБАЕВ, А.В., САКАЕВА, Д.Д., МЕНЬШИКОВ, К.В., СУЛТАНБАЕВА, Н.И., МУСИН, Ш.И., Izmailov, A.A., Nasretdinov, A.F., Sultanbaev, A.V., Sakaeva, D.D., Menshikov, K.V., Sultanbaeva, N.I., Musin, Sh. I. (2021)
, the authors have analyzed works on the efficacy of the most interest-ing representative of TKIs
Безопасность и эффективность рибоциклиба в комбинации с летрозолом в расширенной популяции пациентов с HR+/HER2- распространенным раком молочной железы: анализ данных подгруппы пациентов из России в рамках исследования IIIb фазы CompLEEment-1
Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase IIIb CompLEEment-1 study
Zhukova, Liudmila G., Bolotina, Larisa V., Dvornichenko, Victoria V., Fadeeva, Natalia V., Ganshina, Inna P., Grechukhina, Katerina S., Hasanova, Alfiya I., Kislov, Nikolay V., Kudryavtsev, Igor Yu., Manikhas, Alexey G., Musaeva, Natalia E., Nizhegorodtseva, Alexandra A., Sadikova, Olga E., Sakaeva, Dina D., Snegovoy, Anton V., Stroyakovskiy, Daniil L., Tjulandin, Sergei A., Trishkina, Ekaterina A., Vladimirova, Liubov Iu., Volkov, Nikita M., Kostalanova, Yulia V., Жукова, Л.Г., Болотина, Л.В., Дворниченко, В.В., Фадеева, Н.В., Ганьшина, И.П., Гречухина, К.С., Хасанова, А.И., Кислов, Н.В., Кудрявцев, И.Ю., Манихас, А.Г., Мусаева, Н.Э., Нижегородцева, А.А., Садикова, О.Е., Сакаева, Д.Д., Снеговой, А.В., Строяковский, Д.Л., Тюляндин, С.А., Тришкина, Е.А., Владимирова, Л.Ю., Волков, Н.М., Косталанова, Ю.В. (2024)
Safety and efficacy of ribociclib in combination with letrozole in an extended population
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN
Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili (2017)
the safety, tolerability, pharmacokinetics/pharmacodynamics, and efficacy of three different weekly MOD-4023
A RANDOMIZED PHASE 2 STUDY OF LONG-ACTING TRANSCON GH VS DAILY GH IN CHILDHOOD GH DEFICIENCY
Chatelain, Pierre, Malievskiy, Oleg, Radziuk, Klaudziya, Senatorova, Ganna, Abdou, Magdy O., Vlachopapadopoulou, Elpis, Skorodok, Yulia, Peterkova, Valentina, Leff, Jonathan A., Beckert, Michael (2017)
the pharmacokinetics, pharmacodynamics, safety, and efficacy of weekly TransCon GH to that of daily GH in prepubertal
Effect of mesenchymal stem cell-derived exosomes on the inflammatory response after stroke
Beylerli, Ozal, Gareev, Ilgiz, Shi, Huaizhang, Ilyasova, Tatiana (2024)
challenge in effectively treating neuroinflammation to improve treatment efficacy. In this context
Therapeutic effect of natural polyphenols against glioblastoma
Beylerli, Ozal, Beilerli, Aferin, Shumadalova, Alina, Wang, Xiaoxiong, Yang, Mingchun, Sun, Hanran, Teng, Lei (2022)
. Although these beneficial effects are promising, the efficacy of natural polyphenolic compounds in GBM
DIAGNOSIS AND TREATMENT OF MILLER CLASS I GINGIVAL RECESSION USING FREE CONNECTIVE TISSUE AUTOGRAFT FROM THE HARD PALATE. CLINICAL OBSERVATION
Farkhshatova, R, Gerasimova, L, Usmanova, I, Daurova, F, Golub, A, Aletdinova, S (2022)
treatment. The average percentage efficacy of recession coverage in the study group was - 84%. Pain
BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY FOR STAGE III OR IV HODGKIN'S LYMPHOMA
CONNORS, J.M., SAVAGE, K.J, JURCZAK, W, LECH-MARANDA, E., SMOLEWSKI, P, WALEWSKI, J, STRAUS, D.J., YOUNES, A., ANSELL, S.M., KIM, W.S., GALLAMINI, A., ALEKSEEV, S., ILLÉS, A., ROSTA, A., PICARDI, M., ZINZANI, P.L., OKI, Y., FELDMAN, T., BARTLETT, N.L., CHEN, R., RAMCHANDREN, R., CUNNINGHAM, D., RADFORD, J., JOSEPHSON, N.C., SONG, E., SACHS, J., JOLIN, H.A., HUEBNER, D., LIU, R., LIPATOV, O.N. (2018)
, 0.73 [95% CI, 0.45 to 1.18]; P=0.20). All secondary efficacy end points trended in favor of A
Эффективность комбинации ленватиниба с пембролизумабом у больных распространенным почечно-клеточным раком
Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma
Volkova, M.I., Kalpinskiy, A.S., Goncharova, O.A., Menshikov, K.V., Stativko, O.A., Karabina, E.V., Dergunov, A.S., Polshina, N.I., Aleksandrova, E.N., Lebedinets, A.A., Panov, A.K., Sultanbaev, A.V., Usynin, E.A., Volkonsky, M.V., Mikhalyuk, V.V., Zukov, R.A., Anzhiganova, Yu.V., Gusniev, M.A., Igumnova, E.N., Kuzmicheva, S.V., Pokataev, I.A., Olshanskaya, A.S., Pervakova, N.I., Parsadanova, E.L., Sannikova, T.A., Bystrov, A.A., Dubovichenko, D.M., Mukhitova, M.R., Chubenko, V.A., Shkret, K.A., Gorshenina, M.N., Semenov, A.V., Davlatova, M.K., Kosareva, A.E., Lutoshkina, O.A., Maslova, O.A., Makhnutina, M.V., Mishina, A.V., Murzalina, M.Zh., Podyacheva, O.A., Kalinin, S.A., Mailyan, O.A., Safarova, A.R., Semenova, K.O., Strokova, M.A., Urashkina, E.Yu., Shmygina, O.S., Novikova, O.Yu. (2024)
Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell
Опыт проведения первого всероссийского хакатона в кардиологии Cardio data hack
Experience of conducting the first Russian cardiology hackathon Cardio data hack
Lakman, I.A., Duplyakov, D.V., Villevalde, S.V., Zagidullin, N.Sh., Лакман, И.А., Дупляков, Д.В., Виллевальде, С.В., Загидуллин, Н.Ш. (2023)

Страница 6 из 32

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год